. Key questions regarding MPS functionality still remain. The tissue-specific cues that enable MPS cells to effectively trigger adaptive immune responses in tightly regulated, immune-privileged sites are poorly understood and, in this Review, we focus on this in the context of certain compartments of the visual system. Wayne Streilein described immune privilege as "nature's way" (REF. 11 ) of providing protection from deleterious immune responses to highly delicate and vital organ systems. These include the visual, central nervous and reproductive (testis and pregnant uterus) 12, 13 systems. Certain mechanisms of immune privilege vary between these systems and, as seen in the eye (FIG. 1) , even vary across different compartments within a given system 14, 15 . Some facets of immune privilege have also been recognized in the pathogenesis of certain diseases, including immune evasion by pathogens or in tumour settings 16, 17 . Thus, this area of research has broad implications in health and disease, as previously reviewed by Niederkorn 18 . A separate but also important problem involves potential specialized functions for distinct MPS populations in certain neurodegenerative diseases of the CNS, including in the retina (FIG. 1) . Although immune privilege (or loss thereof) has been related to the pathogenesis of neurodegeneration and has been addressed elsewhere [19] [20] [21] [22] [23] [24] , we do not focus on this area in this Review. Instead, we examine recent findings establishing that monocyte-derived cells are recruited to the CNS parenchyma in disease and are derived from the bone marrow 25, 26 , whereas adult microglia are mainly derived from erythro-myeloid progenitor cells formed during primitive haematopoiesis [5] [6] [7] [8] 10, 27 . More specifically, we evaluate the question of whether these cells are intrinsically different at a functional level given their distinct ontogenies 9 . In the visual system, which we concentrate on in this Review, the themes of both immune privilege and neuro degeneration have been extensively studied. We first explore newly appreciated pathways that may explain how MPS cells activate adaptive immune networks with respect to the immune-privileged cornea and retina. We then shift topics, to examine recent findings regarding MPS cell function in neurodegenerative diseases of the retina, such as glaucoma, retinitis pigmentosa and age-related macular degeneration (AMD). Both parts of the Review also draw parallels to new findings concerning MPS biology in the CNS and periphery.
Eye immune privilege breach and the MPS The concept of immune privilege has been revised in recent years, as highlighted in BOX 1. New questions have arisen regarding how MPS cells function in immune-privileged sites. On the one hand, subverting immune privilege is permissive to autoimmunity, as recently reviewed in REF. 28 ; on the other hand, subversion promotes immune defences that are needed in the context of infectious diseases. Recent findings in the eye suggest several ways in which DCs may accomplish this feat in certain compartments of the eye. The types of DCs and macrophages that are harboured in the cornea have been reviewed elsewhere 29, 30 . In addition, it is important to note that not all insults to the eye result in a permanent loss of immune privilege 14, 31 , but we do not directly address this area in this Review. Instead, we concentrate on novel concepts that include lymphatic vessel outgrowth (that is, lymphangio genesis) into the immune-privileged cornea (which is not part of the CNS) and peripheral nerve signals that are capable of causing a breach in this immune privilege. Finally, we also review recent data implicating gut commensal microorganisms in T cell activation and consequent autoimmune attack of the retina (which is part of the CNS). We discuss the role of DCs in these contexts and the homeostatic and pathological implications in humans.
Lymphangiogenesis overcomes immune privilege in the cornea. Although there is a paucity of lymphatics within immune-privileged sites (except for the testis 32 ) under normal physiological conditions, access to blood vessels or drainage pathways in lymph vessels of adjacent structures has been recognized, as recently reviewed 14 . Examples include drainage from cerebrospinal fluid through meningeal lymphatics 33, 34 , eye anterior chamber into extraorbital lymphatic vessels 35 , and the maternalfetal interface into uterine lymphatics 36, 37 . Hence, we use the term 'pauci-lymphatic' as a designation for such sites. The cornea is one such example of a pauci-lymphatic 38 , immune-privileged site 39 . Specifically, the cornea proper is completely avascular, whereas the limbus (the very periphery of the cornea) is amply vascularized (FIG. 2) .
Numerous mechanisms that maintain this 'angiogenic privilege' (REF. 40 ) have been defined, such as the repression of certain pro-lymphangiogenic factors. One example is via suppression of vascular endothelial growth factor C (VEGFC) expression, which is partly mediated by membrane type 1-matrix metalloproteinase signalling that suppresses macrophage production of VEGFC 41 . Similarly, the matricellular protein thrombospondin 1 (TSP1) also suppresses macrophage expression of VEGFC, as described by Masli and colleagues 42 . Another mechanism involves inhibiting the expression of the VEGFC receptor, VEGF receptor 2 (VEGFR2), which is partly mediated through forkhead box protein C1 (FOXC1) -a member of the large forkhead box transcription factor family involved in vascular development 43 . Finally, VEGFC decoy receptors also inhibit lymphangiogenesis by sequestering VEGFC away from lymphatic endothelial cells 44, 45 . Subversion of these inhibitory processes occurs most notably under certain inflammatory settings, as we have shown in the allergic eye disease (AED) model 46, 47 and others have shown in models of corneal transplantation 48 , herpes simplex virus-1 (HSV-1) keratitis 49 and dry eye disease 50 . In such settings, an outgrowth of lymphatics from the limbus invades the cornea (FIG. 2) . In some cases, there is also a concurrent invasion of blood vessels (FIG. 2) . For these reasons, the cornea has been a widely used model site to study the mechanisms underpinning pathological neovascularization -a noteworthy example is the work in tumour angiogenesis by Judah Folkman 51 . To overcome the aforementioned inhibitory activities in the cornea, certain factors are switched on 52 . Such factors, which are expressed during inflammation, include the carbohydrate-binding protein galectin 8 (REF. 53 ) and interleukin-17 (IL-17) 50 , and contribute to corneal lymphangiogenesis through lymphatic endothelial cell sprouting and proliferation, respectively. Additional factors involved in overcoming immune privilege in the cornea have been reviewed elsewhere 54 . Evidence of limited drainage in the cornea was shown by Collin 38 . With respect to restricted migration of antigen-laden DCs to the lymph nodes, these ideas Nature Reviews | Immunology
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Figure 1 | Immune-privileged sites of the eye. The eye is divided into an anterior and a posterior segment. The anterior segment includes the cornea, anterior chamber, iris and lens. The posterior segment includes the vitreous, retina and choroid. Immune-privileged sites and tissues of the eye include the cornea, anterior chamber, lens, vitreous, retina and subretinal space. Cells of the mononuclear phagocyte system (MPS) that are found in different parts of the eye include: dendritic cells (DCs) and macrophages 29 in the cornea; DCs and macrophages 30 in the iris; macrophages 30 in the ciliary body; macrophages 30 in the choroid; and microglia 119 in the retina.
are mainly derived from observations in the inflammatory lymphangiogenic setting 55 , in which their ability to migrate and consequently to activate T cells is augmented. Their ability to activate T cells was shown in the context of abrogated immune privilege in the corneal transplant model 56 . However, the isolated role of lymphangiogenesis might not be identified in this system because inflammation also results in increased frequencies of DC maturation and egress into the lymphatics 57, 58 , as well as recruitment of monocyte-derived cells 59 . One study showed that lymphangiogenesis can be experimentally inhibited (using an integrin inhibitor) in the presence of corneal inflammation 60 . In so doing, the authors observed that consequent T cell activation is reduced despite the abrogation of corneal immune privilege 60 . However, the authors did not quantify DC migration to the lymph node. Other evidence that corneal lymphangiogenesis, and possible migration of DCs, may lead to a breach in immune privilege can be garnered from reports showing the presence of corneal autoimmune T cell responses associated with lymphangiogenesis 61 . Examples were shown in a SjÖgren syndrome-like model of corneal disease and in models of dry eye disease 42, 46, [62] [63] [64] . In short, considerable advances have been made in understanding how the immune-privileged cornea maintains its pauci-lymphatic state and how its subversion is associated with augmented DC migration and T cell responses. However, current methods used to stimulate lymphangiogenesis require an inflammatory insult, which in and of itself may trigger augmented DC migration. Work from our group and others helped to reveal the role of CC-chemokine receptor 7 (CCR7) in migration of corneal DCs to the lymph nodes 29, 46, [65] [66] [67] [68] , which could be another way that DC migration may be regulated independently of lymphangiogenesis 66 . Corneal abrasion was also shown to increase antigen drainage to the lymph nodes, signifying a key role for the epithelium in maintaining immune privilege 69 . Finally, the relative contribution of other factors, such as neuropeptides 70 and corneal nerves in immune privilege is also important, as we discuss in the section below.
Peripheral nerve regulation in breaching corneal immune privilege. Understanding how immune responses are altered through the hardwiring of the nervous system's reflex arcs is an emerging field [71] [72] [73] and recent evidence suggests a role for this process in breaching immune privilege. This hard-wired activity can facilitate rapid adaptation to environmental perturbations for maintenance of tissue homeostasis. It was recently shown how this neuro-immune reflex in the gut lumen regulates macrophage function distally in the muscularis externa, as pathogens activate extrinsic sympathetic neurons that innervate this site 72 . With respect to the eye, another fascinating study revealed the possible existence of a putative neuro-immune reflex capable of breaching corneal immune privilege 74 . The authors showed that a certain nerve injury in one cornea causes the loss of immune privilege in the other cornea, and showed further data suggesting that breach of immune privilege in both eyes is coupled through such a reflex response (FIG. 3) .
Authors of this cornea study took advantage of the unique acceptance rates in the mouse corneal transplant model 75 to examine the loss of immune privilege. Experiments in which the donor cornea and recipient mouse are fully MHC-mismatched show a spontaneous 50% acceptance rate, which is attributed to immune privilege. By contrast, the same donor-to-host combination placed in conventional sites, such as the skin, yields 0% acceptance. Corneal immune privilege also exists in humans, as corneal transplantation is the only type of solid organ or tissue graft in which HLA tissue typing is not carried out as standard 76 . When the authors severed the nerves in a certain manner in one cornea, the expected spontaneous graft acceptance in the fellow eye was abolished in mice, which was associated with increased allogeneic T cell activity. Hence, severing corneal nerves in one eye breaches immune privilege of the unmanipulated contralateral cornea. A similar finding was corroborated by a study involving laser burn injury to the retina in mice 77 . Intriguingly, there is an analogous human condition called sympathetic ophthalmia, in which a penetrating injury to one eye results in a uveitic inflammation in both eyes 78 , although a neurogenic aetiology for sympathetic ophthalmia has not been established.
Multiple lines of evidence suggest that this bilateral immune privilege breach of the cornea is a neuroimmune reflex. First, the factor required to cause this response was shown to be the neuropeptide, substance P 74 . Second, elevated levels of substance P were detected in the contralateral eye more than 12 days after the severing procedure, whereas increased neuro peptide in the serum was only detectable for several days. Thus, rather than a possible role for systemic or circulating substance P, the data suggest that the nerves in the unmanipulated contralateral cornea are the source of this neuropeptide. If true, it may implicate a putative reflex that may travel via afferent axons, perhaps by way of the trigeminal ganglia (FIG. 3) . Intriguingly, this response does not follow normal circuitry, which has previously been reviewed by Tracey 79 . However, this specific pathway in the cornea has yet to be definitively shown.
Box 1 | Evolution of immune privilege
Sir Peter Medawar coined the term 'immune privilege' in the 1940s, using it in the context of transplant immunology. In contrast to allogeneic grafts placed within conventional sites such as the skin, those placed in the brain parenchyma or the eye anterior chamber were protected from the fate of immune rejection for extraordinarily long intervals or even indefinitely, in the absence of neovascularization 138 . He also made the observation that privileged sites lacked the presence of patent lymphatic vessels, which at the time explained his theory for how these sites were afforded 'privilege' from certain adaptive immune responses. However, new findings suggest that nonconventional pathways of drainage permit antigen from these sites to access lymphatic networks or the spleen 34, 36, 78, 139, 140 . However, this level of access is limited 38 and is thought to be preferential to activation of regulatory immune networks 141 , such as anterior chamber-associated immune deviation (ACAID) described by Wayne Streilein and colleagues 11 . Furthermore, innate immune responses are suppressed in immuneprivileged sites 142 and breach of the blood-brain barrier by T cells is fairly limited in the steady state 15 .
The exact mechanism by which substance Pproducing nerves in the contralateral cornea cause augmented T cell responses during immune privilege breach remains an unanswered question. One possibility is that substance P causes qualitative pathogenic changes in corneal mononuclear phagocytes, as we have previously hypothesized 80 . For example, it was shown that skin sensory nerves drive dermal DCs to trigger a psoriasiform disease 81 . Similarly, another group showed that expression of calcitonin gene-related peptide by nociceptive fibres activated dermal DCs to promote cutaneous candidiasis resistance 82 . In the gut, one study identified a microbiota-driven crosstalk between muscularis macro phages and enteric neurons that regulate peristalsis 83 . In the eye, a close proximity between nerves and myeloid cells in the cornea has also been documented 80, 84, 85 , and recent findings suggest that DC production of ciliary neurotrophic factor contributes to corneal nerve regeneration 84 . Hence, it is conceivable that substance P-expressing corneal nerves that cause a breach in immune privilege may do so by altering mononuclear phagocytes in a manner that promotes activation of T cells upon certain provocation.
The possible evolutionary advantage for this putative neuro-immune reflex may be in the augmentation of host immune defence against blinding bilateral corneal infection. Acanthamoeba keratitis causes corneal nerve damage 86 and thus a unilateral infection may trigger an immune privilege breach in the contralateral eye. Such a result would potentially prevent a host from succumbing to bilateral corneal blindness, and there is some evidence in human Acanthamoeba keratitis to support this concept 87 . Future work is needed to address such a possibility. Whether commensal microorganisms may differentially modulate this response also needs to be resolved, which we review in the section below.
The gut microbiota enables evasion of immune privilege in the retina. The underpinning mechanisms for why the gut microbiome has such a marked effect on host physiology is another fascinating and timely area of investigation and may be relevant to how DCs activate T cell responses that affect the immune-privileged retina 88 . However, for reasons not understood, the surface of the normal eye has an extraordinarily low density and diversity of commensal bacteria, which is dissimilar to any other barrier site (reviewed in REF. 89 By contrast, the normal gut microflora has been shown to influence retinal health and the CNS. Recent evidence suggested that gut microbiota-dependent signals activate T helper 17 (T H 17) cells that are specific for the retinal antigen interphotoreceptor retinoid-binding protein (IRBP; also known as RBP3), which causes experimental autoimmune uveitis (EAU) 92 . This particular model results in spontaneous development of uveitis by 2 months. A similar phenomenon was shown with encephalomyelitic T cells in a model of experimental autoimmune encephalomyelitis (EAE) 93 , which is induced by active immunization with the myelin-related antigen myelin oligodendrocyte glycoprotein (MOG). Similarly, it was reported that normal gut flora is associ ated with increased T H 17 cell responses and clinical disease in EAE 94 . Interestingly, this report showed that the same augmented disease response occurred when the gut flora was monocolonized with the specific commensal segmented filamentous bacteria (SFB) and thus implicated these bacteria in EAE immunopathogenesis. Nature Reviews | Immunology Similarly, the mouse colony in the EAU study mentioned above harboured SFB 92 . Furthermore, R161 T cell receptor transgenic T cells, which are specific for IRBP, were activated independently of their cognate antigen, which could suggest a similar role for SFB. However, the authors found that SFB depletion with the antibiotic vancomycin did not abrogate EAU. Hence, the gut commensal species that produces the signals that led to the activation of uveitogenic T cells in this model remains unknown.
To summarize, the MPS has various ways in which to activate adaptive immune responses in eye immune privilege. In the cornea, evidence suggests that the presence of lymphangiogenesis amplifies the migration of antigenladen DCs to the lymph nodes for consequent activation of T cell responses. Alternatively, (somato sensory) nerves in the cornea can release neuropeptides that breach corneal immune privilege and permit activation of T cells. Potentially, this pathway enables corneal DCs to activate T cells in the lymph nodes, but this needs to be confirmed. Finally, studies mentioned above suggest that commensalderived antigens from non-privileged distal sites lead to the activation of T cells that can, in turn, attack host cells in immune-privileged tissues. It is possible that the DCs in the gut lamina propria are stimulating these T cells in EAU, but this point also needs to be tested. In addition, pathogens can stimulate immune responses via innate lymphoid cells or via γδ T cells 95 . Finally, gut commensals can affect the CNS, by altering microglial activity, which we also do not address in this Review 96, 97 . However, the focus of the section below is on the role of microglia (as well as monocyte-derived cells) in the context of retinal degenerative diseases.
The MPS and neurodegeneration in the retina
The recent paradigm shift that adult microglia are derived from fetal origins as opposed to adult definitive haematopoiesis is reshaping our knowledge about the isolated role of these cells in neurodegenerative diseases. Within the CNS parenchyma, including the neural retina, microglia constitute the majority of the MPS (FIG. 4) . Efforts have shifted to better understand the relationship between positive and negative effects of microglia and monocyte-derived cells in neurodegeneration, including in the retina. Such work may lead to novel therapies to preserve neuronal function by individually targeting these populations 98 . This section examines the role of microglia and monocyte-derived cells in retinal neurodegenerative disease, although other immune and non-immune cells also have a role. We specifically address blinding diseases that are not widely considered to have an immune aetiology. One such disease is glaucoma, which involves axonal degeneration and dropout of retinal ganglion cells (RGCs) (FIG. 4) , leading to blindness. Also emphasized in this section is animal work on retinitis pigmentosa, which is an 'umbrella' term for numerous inherited conditions that are characterized by degeneration of photoreceptor cells (FIG. 4) . We also examine age-related macular degeneration (AMD) -a condition in which clinical disease begins at the level of the choroid, which is just below the neural retina (FIG. 4) . For these diseases, we review new reports indicating a central role for mononuclear phagocytes in disease pathobiology and examine the possible distinct roles of microglia and monocyte-derived cells in such settings.
Microglia and the classic complement cascade in RGC degeneration. Our understanding of microglia has evolved considerably and, in addition to appreciating their roles as immune sentinels of the CNS, we are now aware of their vital role in synaptic maturation and maintenance [99] [100] [101] [102] . In health, the involvement of microglia and the classic complement cascade has emerged as a central factor in synaptic plasticity, as investigated in the Nature Reviews | Immunology visual system 103 . An important study by Barres and colleagues 104 helped to initiate this line of research through their finding that complement component 1q (C1q), which is the initiating protein in the classic complement cascade, is needed to eliminate inappropriate synaptic connections during postnatal development. Stevens and colleagues 105 then went on to show that microglia carry out this elimination process, as shown by examining the anatomical refinement of connections between the retina and geniculate ganglion. Specifically, they showed that neuronally derived C1q tags excess synapses and consequently selects them for elimination by microglia. These studies proved that microglia are crucial to maintaining healthy synapse function and identified the mechanism by which this activity occurs at the level of RGCs and retinogeniculate connections (FIG. 4) .
The classic complement cascade also has a pathological role, as recently discovered in certain neuro degenerative diseases. In mice, the healthy adult CNS has a low presence of C1q, but in the adult retina, C1q becomes upregulated and synaptically relocalized in RGCs in DBA/2J mice 104 . This strain spontaneously develops a glaucoma-like disease, which includes degeneration of RGCs 106 , and genetic deletion of C1q helps to protect these mice from this fate 107 . A remarkably similar finding in Alzheimer disease models was recently discovered 108 , possibly suggesting parallel mechanisms in glaucoma. Authors showed that C1q associated with synapses before overt plaque deposition and that abrogating the classic complement cascade reduces the extent by which microglia eliminate early synapse loss in the hippocampus 108 . A similar mechanism was shown in a neuroinvasive disease mouse model of West Nile virus infection 109 . Of note, dysregulation of complement, albeit the alternative cascade, is implicated in AMD -a different neuro degenerative condition 110, 111 . However, patho genesis in AMD is thought to involve upstream accumulation of pathological lipid deposits under the retina, as opposed to synapse elimination. This topic has been reviewed elsewhere 112 . These studies underscore a dichotomous nature of microglia. On the one hand, C1q enables microglia to shape healthy neuronal connections in the visual system and, on the other hand, the inappropriate reactivation of C1q in adulthood is suspected to make microglia pathogenic in glaucoma-like neurodegeneration. It is undefined as to whether this mechanism is involved in photo receptor degeneration, which we focus on in the section below. In addition, infiltrated monocytes are also involved in retinal degeneration, including in glaucoma models 113 . Hence, discriminating such recruits versus microglia and determining their respective unique involvement in retinal degeneration is another important area of research.
Phenotypic differences of microglia versus monocytederived cells in the retina.
Although it is now understood that microglia have distinct origins from monocytederived macrophages that are recruited into the inflamed CNS 4 , distinguishing between the two popu lations is technically challenging. Their different origins were shown in a seminal study that used parabiosis to show (LGN) , where the signal is passed to neurons that carry it to the visual cortex. Microglia reside in and extend their processes throughout the synaptic regions in the neural retina. Retinal pigmented epithelium (RPE) is very important for the visual cycle function and this has tight junctions and other factors that aid in the maintenance of retinal immune privilege. The area between the RPE and the photoreceptors is designated the subretinal space. Beneath the RPE are the choroid and sclera, which constitute the larger outer structure of the eye. In age-related macular degeneration (AMD), pathogenesis begins at the level of the choroid, whereas photoreceptors are the primary site of degeneration in retinitis pigmentosa. By contrast, the RGCs and their axons degenerate in glaucoma. SC, superior colliculus.
that microglia are not replaced by circulating monocytes, but are instead a long-lived, self-renewing population 25, 26 . Subsequent findings by another group showed that adult microglia are seeded in utero by yolk sac-derived progenitor cells 5 . Of note, this ontogeny is in contrast to the origins of macrophages that reside in the periphery, as macrophage populations from peripheral tissues show mixed ontogeny (that is, they can comprise fetal liverderived monocytes and/or adult bone marrow-derived monocytes) 27, [114] [115] [116] [117] . The retina in degenerative conditions is permissive to the recruitment of monocytes, which differentiate into macrophages 113, [118] [119] [120] [121] . These recruits share phenotypic markers with microglia. Numerous approaches have been devised to study these two populations independently, but many have notable drawbacks (TABLE 1) . These approaches include mice bearing a green fluorescent protein (GFP) reporter gene knock-in under the promoter control of the fractalkine receptor CX 3 Cchemokine receptor 1 (CX 3 CR1; known as CX3CR1 GFP/WT mice), and a red fluorescent protein (RFP) under the control of the CC-chemokine receptor 2 (CCR2) promoter (CCR2 RFP/WT mice). However, microglia and monocyte-derived macro phages are both CX 3 CR1 + and CCR2
-(REF. 119 ) and thus this approach cannot faithfully discriminate between the two populations. Another approach uses bone marrow chimaeras to distinguish between microglia (host-derived) and recruited monocytes (donor-derived). However, the combination of irradiation and bone marrow transplantation (BMT) results in low-grade pathology and the recruitment of monocyte-derived cells (or their precursor cells) into the retina 26, 119, 121, 122 . Parabiosis is another approach that can be used to circumvent this problem 26 , but drawbacks include partial blood chimerism and technical challenges.
Only a Cre-Lox approach has been shown to faithfully identify the two compartments simultaneously, as devised independently by two groups 100, 116 and subsequently established by us in the retina 119 . The strategy uses CX3CR1
CreER transgenic mice for conditional Cre-LoxP-mediated modifications of CX 3 CR1-expressing cells, including microglia, monocytes and macrophages 100, 116, 119 . The long-lived microglia retain those modifications but the short-lived monocytes are replaced by non-modified monocytes within a few weeks (FIG. 5) . Our group has mated the CX3CR1 YFP−CreER mouse to an R26 RFP Cre reporter mouse 119 . After tamoxifen activation of Cre and a short 'wash out' period, we were able to faithfully discriminate RFP-labelled microglia from non-labelled monocyte-derived cells in the light-induced model of retinal degeneration. Furthermore, we found that retinal microglia have a unique surface marker phenotype (that is, CD45 Microglia and monocyte-derived cells in photoreceptor degeneration. Investigation of the non-redundant contributions of microglia and monocyte-derived cells in neurodegenerative diseases has only recently begun but early studies suggest important differences 125 . In a model of light-induced retinal degeneration, our laboratory used the CX3CR1 CreER−YFP ;R26 RFP mouse described above to definitively discriminate RFP-labelled microglia from non-labelled monocyte-derived macrophages 119 (FIG. 5; TABLE 1). Interestingly, these two cell types localized to different regions of the photoreceptor cell. Whereas the majority of microglia moved to below the photoreceptor outer segment, monocyte-derived macrophages appeared throughout the depth of the degenerating retina, including next to the photoreceptor soma. Hence, it may be possible that microglia are removing distal debris of the outer segment, whereas monocyte-derived cells may be phagocytosing around the photoreceptor soma; this remains to be shown. Evidence of differential localization of MPS cells in the spinal cord was also recently shown in EAE. Authors showed that monocyte-derived macrophages made axoglial contact, whereas microglia processed debris at a more distal location 125 . The functions of specific MPS populations in retinochoroidal disease were also recently reported 126 . The authors used a mouse model that mimics certain features of AMD pathogenesis. In this model, a laser burn is administered to rupture Bruch's membrane, which separates the retinal pigment epithelium (RPE) and the choroid. This perturbation leads to the outgrowth of new blood vessels and vascular leakage into the retina, simi larly to what is seen in neovascular AMD. The authors used CX3CR1 CreER mice to delete the floxed gene for interferon-α/β receptor 1 (Ifnar1) before laser injuring retinochoroidal macrophages, which include retinal microglia and putative CX 3 CR1 + macrophages in the choroid. Strikingly, the severity of choroidal neovascular lesions and vascular leakage was worsened by conditional deletion of IFNAR1 in retinochoroidal macrophages, which suggests a central protective role for IFNAR1 signalling. Although these findings are important, it was not determined whether the effect was due to conditional loss of IFNAR1 in microglia, in choroidal macrophages or from both populations (TABLE 1) . This question is important because the injury originates at the choroid and consequent vascular leakage is due to chor oidal neovessels. Regarding human disease, although interferon-α2 (IFNα2) therapy has been tried in patients with AMD with little success 127 , not much is known about IFNβ therapy in this regard.
With respect to retinitis pigmentosa, it was shown that MPS cells actively phagocytose injured photoreceptors 128 . The authors generated a CX3CR1 After tamoxifen administration, microglia retain reporter expression indefinitely, whereas circulating monocytes retain expression of the reporter for 4 weeks. We refer to this time frame as the 'wash out' period, which correlates with monocyte turnover rates from the bone marrow. Hence, faithful reporter visualization in microglia alone requires inclusion of the wash out period.
selective depletion of all CX 3 CR1 + cells, which includes microglia and monocyte-derived cells (TABLE 1) . This transgene combination was bred onto mice homozygous for the retinal degeneration 10 (rd10) mutation of phosphodiesterase 6B (Pde6b), which develop photo receptor degeneration within the first 3 weeks of life. With continuous depletion of CX 3 CR1 + phagocytes, mice showed delayed and reduced degeneration up to postnatal day 50. However, methods used could not discriminate whether microglia and/or monocytederived cells were the effector phagocytes because both populations would be depleted in this system (TABLE 1) . Furthermore, depletion was not started until postnatal day 21, a time when monocyte recruitment presumably had already begun, as retinal levels of CC-chemokine ligand 2 (CCL2; which signals via CCR2 to promote monocyte recruitment) are high at this time point 129 . Nonetheless, these findings suggest that the mononuclear phagocytes have important pathogenic roles in certain forms of inherited degeneration.
Other reports suggest an isolated contribution of monocyte-derived cells to the pathobiology of photoreceptor degeneration in mouse models, although the effector mechanisms are not completely understood. It was shown that monocyte-derived cells, recruited through CCR2, contribute to the spontaneous agerelated photoreceptor degeneration that occurs in CX 3 CR1-deficient mice 120 , and a similar pathway was also found to be relevant in human AMD and photoreceptor degeneration 130 . Similarly, another study showed that CCR2-deficient mice bred onto Pde6b rd10 mice had reduced photoreceptor degeneration 129 , although the effect was less marked than what was seen in the aforementioned report using CX3CR1 CreER ;R26 DTA mice 128 . Finally, the type 2 cytokine, IL-33, has recently emerged in the literature as a player in retinal degenerative disease. New findings suggest that pathogenic monocyte recruitment in photoreceptor degeneration is mediated by IL-33, which is produced by Müller glia 131 . For reasons not fully understood, another group found that IL-33 was not relevant in recruitment activity, albeit using a different model system, the laser-induced chor oidal neovascularization model. In this system, IL-33 had a central role in regulating pathological neovascularization at the level of the choroid 132 . By contrast, IL-33 does have a role in recruitment of monocytes following optic nerve crush in mice 133 (which models aspects of glaucoma), as well as in experimental spinal cord injury. Intriguingly, this monocyte-recruitment activity had a reparative role in the disease setting, as previously shown in a model of glutamate intoxication of RGCs 113 . Hence, monocytederived cells are not universally pathogenic in all forms of retinal degeneration.
To summarize, in the steady state, microglia are important for maintaining healthy synapses. In degenerative diseases, microglia are not always protective and monocyte-derived cells are not always pathogenic. Furthermore, recent findings show that both the local environment and epigenetics shape macrophage identity and function in the steady state [134] [135] [136] [137] , which may suggest that monocyte-derived cells can take on microglial functionality in neurodegeneration, or vice versa. Hence, future work is required to continue to understand these different compartments and to help to determine if and how therapies can be designed to specifically target either cell type 98 .
Concluding remarks
The advent of new techniques for assessing the ontogeny of MPS cells has increased our understanding of the roles of these cells in breaching immune privilege and in the pathobiology of neurodegenerative disease. Ontogeny research has helped to show that DCs are indeed a unique branch of the MPS and, in turn, will facilitate the discovery of DC-specific mechanisms in the formation of adaptive immunity relevant to privileged sites, including the cornea and retina. Ontogeny studies have also helped to distinguish microglia from monocyte-derived cells and the non-redundant functions of these cell types in neurodegeneration (including in that of the retina) are now being addressed. Although complexities and unanswered questions still remain, the reciprocal relationship between research advances in ontogeny and function, as outlined in this Review, is augmenting our understanding of the MPS. In so doing, the vast implications of these cells in health and disease promises to become fully realized, for the visual system and throughout the human body.
